The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of primary versus metastatic tumor tissue sources when designing panels for whole genome–based tumor-informed ctDNA assays in clear cell renal cell carcinoma.
 
Aaron Seo
No Relationships to Disclose
 
Kieko Hara
Research Funding - NanoString Technologies
 
Alexander Dean Sherry
Employment - MD Anderson Cancer Center
 
Pavlos Msaouel
Honoraria - Exelixis; Mirati Therapeutics; Pfizer
Consulting or Advisory Role - Axiom Healthcare Strategies
Research Funding - Bristol-Myers Squibb (Inst); Gateway for Cancer Research (Inst); Mirati Therapeutics (Inst); Takeda (Inst)
 
Nizar M. Tannir
Stock and Other Ownership Interests - Amgen; BioCryst; Johnson & Johnson/Janssen; Merck; Spdr S&P Pharmaceuticals ETF; Surface Oncology; Vanguard Health Care
Honoraria - AstraZeneca/Merck; Bristol-Myers Squibb; Eisai; Exelixis; Intellisphere; Merck Sharp & Dohme; Nektar; Neoleukin Therapeutics; Oncorena
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Merck Sharp & Dohme; Nektar; Oncorena
Research Funding - Arrowhead Pharmaceuticals (Inst); Bristol Myers Squibb (Inst); Calithera Biosciences (Inst); Exelixis (Inst); Nektar (Inst); Novartis (Inst)
 
Kanishka Sircar
No Relationships to Disclose
 
Jose A. Karam
Employment - MD Anderson Cancer Center; MD Anderson Physician’s Network
Stock and Other Ownership Interests - Medtek; ROM Tech
Honoraria - American Board of Urology; American Urological Association; ECRI; ECRI; Medscape; Merck; Pfizer; Specialty Networks; Syapse
Consulting or Advisory Role - American Board of Urology; American Urological Association; ECRI; Medscape; Medscape; Merck; Pfizer; Specialty Networks; Syapse
Research Funding - Elypta (Inst); Merck (Inst); Mirati Therapeutics (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - American Board of Urology; American Urological Association
 
Christopher Jon Battey
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Ashley Acevedo
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Sarah Ratzel
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Chad Tang
Consulting or Advisory Role - Bayer; Diffusion Pharmaceuticals; Siemens Healthineers
Research Funding - Noxopharm
Patents, Royalties, Other Intellectual Property - I have a patent on the utilization of a monoclonal antibody and we license this for use. We receive royalties <$1000 per year on this license.
Other Relationship - Osler Institute; Wolters Kluwer